Trial Profile
Safety and efficacy of sofosbuvir plus ledipasvir for Chinese hepatitis C patients
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 27 Apr 2016
Price :
$35
*
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 27 Apr 2016 New trial record